Regenerative Medicine Precinical Research
Accelerating Regenerative Medicine Through Mechanistic Insight
Regenerative therapies involve complex biological interactions that cannot be understood through standardized testing alone. Developers need mechanistic insight to optimize products, reduce development risk, and generate evidence that supports decisions.
iFyber supports and clients with integrated scientific evaluation, custom method development, and multidisciplinary expertise designed to answer complex biological questions and accelerate product development.
The Challenge: Understanding Complex Biological Mechanisms
Developing regenerative therapies requires answering complex scientific questions that standardized testing cannot always address.
Mechanisms of Tissue Repair
Understanding how regenerative therapies influence cellular communication, tissue remodeling, and biological pathways that support regeneration.
Biological Signaling & Therapeutic Activity
Evaluating biomarkers such as cytokines, growth factors, and other biological mediators that drive therapeutic performance.
Human-Relevant Models
Selecting models that better replicate human physiology to generate meaningful and translatable preclinical data.
Translational & Regulatory Evidence
Generating scientific data that supports product optimization, development decisions, and regulatory advancement.
Standardized tests often fails to capture the complex biological interactions that influence implant performance.
How iFyber Supports Regenerative Medicine Research
Rather than offering standard testing alone, iFyber partners with clients to design studies that uncover how regenerative therapies function, support product development and scientific goals, and generate meaningful data for
Our multidisciplinary team helps clients with:
- Designing application-specific studies around mechanism of action, intended use, and scientific objectives.
- Evaluating cellular responses, tissue remodeling, inflammation, and biological activity using relevant in vitro and ex vivo models.
- Characterizing cytokines, growth factors, and other biomarkers of therapeutic performance.
- Applying advanced analytical techniques to evaluate product composition, stability, and biological activity.
- Developing customized methods that support product development and optimization, and regulatory submissions.
Integrated Capabilities for Regenerative Medicine
Evaluate the biological pathways, molecular signaling, and cellular responses that influence tissue repair, regeneration, and therapeutic performance.
Support includes:
- Biomarker analysis
- Cytokine profiling
- Growth factor analysis
- Mechanistic biology studies
- Molecular characterization
Evaluate regenerative therapies using in vitro and ex vivo models designed to better reflect human physiology and tissue responses.
Support includes:
- Human tissue models
- Ex vivo tissue models
- Disease-specific models
- Custom biological systems
Understand how regenerative therapies influence cellular behavior, tissue remodeling, and biological repair processes.
Support includes:
- Cell compatibility and viability
- Cell attachment and proliferation
- Cell migration
- Tissue remodeling studies
- Inflammatory response assessment
Evaluate and characterize product composition, stability, that influence therapeutic consistency and performance.
Support includes:
- Analytical chemistry
- Product characterization
- Small molecule quantification
- Stability assessment
- Raman spectroscopy
When existing methods are not enough, we develop customized studies and experimental models that address the unique biological and translational questions associated with your product.
Support includes:
- Custom assay development
- Method optimization
- Product-specific study design
- Novel therapeutic evaluation
- Integrated testing strategies
Beyond Standard CRO Testing
Standard CROs measure endpoints. iFyber helps uncover mechanisms.
A Trusted, Global-Serving Contract Research Organization
Engage with iFyber’s Scientific Team
Connect with iFyber to explore how integrated preclinical research can support your implantable or biomaterial device development program.